Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Dura to launch second Allergan product

June 20, 2000

No Comments

Alcon discovers utility of glutamate antagonists for retinal disorders

June 9, 2000

No Comments

Allergan and Xoma expand rBPI ophthalmic program

June 6, 2000

No Comments

Visudyne therapy receives Canadian approval for treatment of wet AMD

June 2, 2000

No Comments

Angiotech signs license agreement with Alcon for delivery of paclitaxel

May 30, 2000

No Comments

Early use of PDT with verteporfin in age-related macular degeneration

May 24, 2000

No Comments

New agents for cataracts designed by Sankyo

May 22, 2000

No Comments

Squalamine demonstrates preclinical activity in retinopathy

May 19, 2000

No Comments

Ciba Vision and QLT expand strategic alliance for developing new treatments for eye diseases

May 16, 2000

No Comments

Special access program approved for Visudyne in Canada

May 11, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Dura to launch second Allergan product

Alcon discovers utility of glutamate antagonists for retinal disorders

Allergan and Xoma expand rBPI ophthalmic program

Visudyne therapy receives Canadian approval for treatment of wet AMD

Angiotech signs license agreement with Alcon for delivery of paclitaxel

Early use of PDT with verteporfin in age-related macular degeneration

New agents for cataracts designed by Sankyo

Squalamine demonstrates preclinical activity in retinopathy

Ciba Vision and QLT expand strategic alliance for developing new treatments for eye diseases

Special access program approved for Visudyne in Canada

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Ocular RSS

Ocular
RSS